Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.68NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.1.121ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.121ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.121ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.121NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AS.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AS.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AS.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.115ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.115ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.115ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.115NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.127.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.127.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.127.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.127.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.88ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.88ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.88ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.88NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.168ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.168NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AH.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.289ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.289NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.365ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.365ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.365ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.365NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.252ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used